Vocxi Health
Vocxi Health is a diagnostic start-up focused on early disease detection through its innovative MyBreathPrint® system. This noninvasive technology allows for immediate health assessments by analyzing volatile organic compounds (VOCs) in a patient's breath, aiming to revolutionize patient care and improve health outcomes.
Vocxi Health
4100 Hamline Ave Suite: A-200, Arden Hills, MN 55112
What We Do
MyBreathPrint® is a noninvasive, early disease detection system that delivers accurate results with just one minute of breathing: no needles, no radiation, no waiting.
An innovative breath diagnostic system that detects diseases by analyzing VOCs in the breath, providing results in seconds.
Diagnostics
Infectious Diseases
Digital Health Technologies
Key People
News & Updates
Vocxi Health is selected out of 400+ companies to present their poster at the 2024 BLUE KNIGHT™ Symposium.
Vocxi won the best pitch in the Healthcare/Tech Track out of dozens of leading global health technology companies at Venture Summit West.
Executives from Twin Cities-based startup Vocxi Health described their device that will detect disease by sensing chemicals in a person's breath.
Only a fraction of people at high risk for lung cancer are getting screened for the disease even though it kills more in the United States than breast, colorectal and prostate cancers combined.
Minnesota is now eligible to compete for millions in federal dollars after being designated a tech hub by the U.S. Department of Commerce.
The Biden administration designated 31 technology hubs touching 32 states and Puerto Rico to help spur innovation and create jobs in the industries that are concentrated in these areas.